Foreign particulate matter in drug products is a common issue in the pharmaceutical industry that has major impacts on pharmaceutical companies, from both financial and safety aspects. Foreign particulate matter studies are performed for all drug types, both to understand the levels of foreign material present and to submit the product for market release. Typically, these studies are performed by dissolving away drug components, leaving the foreign particulate matter in solution for subsequent filtration and testing. Nasal sprays, however, often utilize the excipient microcrystalline cellulose (MCC) as a filler and stabilizer in the suspension. MCC is exceptionally difficult to dissolve, making foreign particulate matter studies problematic.
Related Posts
AAPS 2017 Development and Validation of a cGMP Compliant Particulate Characterization Database
Reference databases catalog data and information for known materials, process and product related materials, and archived foreign particulate.
RDD 2014: Chemically Specific Analysis of OINDPs: Differentiation of Drug Particle Agglomeration by Raman Chemical Imaging
Proper characterization of pharmaceutical products with respect to particle...
PDA 2016 Annual Meeting: Proactive Versus Reactive Testing for Glass Delamination in Pharmaceuticals
Authors & ContributorsEmily Landsperger